home / stock / bayzf / bayzf articles
Bayer AG (OTC: BAYRY) (OTC: BAYZF) reportedly held an investor call to address concerns after intense scrutiny from investors following a seri...
Monday, Bayer AG (OTC: BAYRY) (OTC: BAYZF) stopped the OCEANIC-AF Phase 3 study early after asundexian showed inferiority to&nb...
Bayer AG (OTC: BAYRY) (OTC: BAYZF) stopped the OCEANIC-AF Phase 3 study investigating asundexian compared to apixaban (a direct oral...
Bayer AG (OTC: BAYRY) (OTC: BAYZF) CEO Bill Anderson announced plans to streamline its operations by cutting back on manag...
Bayer AG (OTC: BAYRY) (OTC: BAYZF) faces another legal setback as a California jury has ruled in favor of a plaintiff who claimed th...
Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially ...
Reuters Walmart Settles Lawsuit Regarding Allegations Of Light-Bulb Patent Infringement Walmart Inc (NYSE: WMT) has reportedly resolved the U...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG Registered Shares Company Name:
BAYZF Stock Symbol:
OTCMKTS Market:
Bayer AG (OTC: BAYRY) (OTC: BAYZF) reportedly held an investor call to address concerns after intense scrutiny from investors following a seri...
Monday, Bayer AG (OTC: BAYRY) (OTC: BAYZF) stopped the OCEANIC-AF Phase 3 study early after asundexian showed inferiority to&nb...
Bayer AG (OTC: BAYRY) (OTC: BAYZF) stopped the OCEANIC-AF Phase 3 study investigating asundexian compared to apixaban (a direct oral...